Literature DB >> 12520520

Regulation of 25-hydroxyvitamin D3-24-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone.

Claudia Zierold1, Jamie A Mings, Hector F DeLuca.   

Abstract

The 25-hydroxyvitamin D(3)-24-hydroxylase mRNA is tightly and reciprocally regulated by 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) and parathyroid hormone (PTH). The upregulation of the 24-hydroxylase by 1,25(OH)(2)D(3) is well established and occurs at the transcriptional level through two vitamin D response elements in the promoter of the gene. However, this induction is blocked by the protein synthesis inhibitor cycloheximide (CHX) indicating a protein component in the regulation pathway. CHX treatment reduced total vitamin D receptor (VDR) protein levels in cells, but reintroduction of VDR and/or retinoid X receptor protein into cells by transfection did not reduce the inhibition by CHX. This indicates that production of another transcription factor or mRNA-stabilizing protein synthesized in response to 1,25(OH)(2)D(3) is required for optimal accumulation of 24-hydroxylase mRNA. PTH downregulates the 24-hydroxylase mRNA by affecting its stability. The half-life of 24-hydroxylase mRNA is reduced 4.2-fold in AOK-B50 cells by PTH. Untranslated regions of the 24-hydroxylase mRNA in reporter gene assays did not confer PTH responsiveness. Further analysis of the coding region of the rat 24-hydroxylase may reveal sites of action of PTH. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520520     DOI: 10.1002/jcb.10341

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  28 in total

1.  Genome-wide analysis of the VDR/RXR cistrome in osteoblast cells provides new mechanistic insight into the actions of the vitamin D hormone.

Authors:  Mark B Meyer; Paul D Goetsch; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2010-02-18       Impact factor: 4.292

Review 2.  Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.

Authors:  James C Fleet; Ryan D Schoch
Journal:  Crit Rev Clin Lab Sci       Date:  2010-08       Impact factor: 6.250

Review 3.  The role of vitamin D in the endocrinology controlling calcium homeostasis.

Authors:  James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2017-04-09       Impact factor: 4.102

Review 4.  Factors inhibiting intestinal calcium absorption: hormones and luminal factors that prevent excessive calcium uptake.

Authors:  Kannikar Wongdee; Mayuree Rodrat; Jarinthorn Teerapornpuntakit; Nateetip Krishnamra; Narattaphol Charoenphandhu
Journal:  J Physiol Sci       Date:  2019-06-20       Impact factor: 2.781

5.  Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question.

Authors:  Salvatore Minisola; Elisabetta Romagnoli; Alfredo Scillitani; Sudhakar D Rao
Journal:  J Endocrinol Invest       Date:  2014-03-20       Impact factor: 4.256

6.  Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.

Authors:  Changcheng Zhou; Mahfoud Assem; Jessica C Tay; Paul B Watkins; Bruce Blumberg; Erin G Schuetz; Kenneth E Thummel
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

7.  Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy.

Authors:  Hala M Alshayeb; Barry M Wall; Arif Showkat; L Darryl Quarles; Therese Mangold
Journal:  Am J Med Sci       Date:  2013-04       Impact factor: 2.378

8.  Chronic ethanol consumption leads to disruption of vitamin D3 homeostasis associated with induction of renal 1,25 dihydroxyvitamin D3-24-hydroxylase (CYP24A1).

Authors:  Kartik Shankar; Xiaoli Liu; Rohit Singhal; Jin-Ran Chen; Shanmugam Nagarajan; Thomas M Badger; Martin J J Ronis
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

9.  Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes.

Authors:  Justine Bacchetta; Jessica L Sea; Rene F Chun; Thomas S Lisse; Katherine Wesseling-Perry; Barbara Gales; John S Adams; Isidro B Salusky; Martin Hewison
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

Review 10.  Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies.

Authors:  Diego Brancaccio; Jürgen Bommer; Daniel Coyne
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.